References
- Baker LA, Allis CD, Wang GG. PHD fingers in human diseases: Disorders arising from misinterpreting epigenetic marks. Mutat Res 2008;647:3–12.
- Gécz J, Turner G, Nelson J, Partington M. The Börjeson-Forssman-Lehman syndrome (BFLS, MIM #301900). Eur J Hum Genet 2006;14:1233–7.
- Dephoure N, Zhou C, Villén J, Beausoleil SA, Bakalarski CE, Elledge SJ, . A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci USA 2008;105:10762–7.
- Lowndes NF, Toh GW. DNA repair: The importance of phosphorylating histone H2AX. Curr Biol 2005;15:R99–102.
- Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER 3rd, Hurov KE, Luo J, . ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007;316:1160–6.
- Landais S, Quantin R, Rassart E. Radiation leukemia virus common integration at the Kis2 locus: Simultaneous overexpression of a novel noncoding RNA and of the proximal Phf6 gene. J Virol 2005;79:11443–56.
- Van Vlierberghe P, Palomero T, Khiabanian H, Van der Meulen J, Castillo M, Van Roy N, . PHF6 mutations in T-cell acute lymphoblastic leukemia. Nat Genet 2010;42:338–42.
- Van Vlierberghe P, Patel J, Abdel-Wahab O, Lobry C, Hedvat CV, Balbin M, . PHF6 mutations in adult acute myeloid leukemia. Leukemia 2011;25:130–4.
- James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C, . A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 2005;434:1144–8.
- Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, . Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004; 350:2129–39.
- Braithwaite AW, Prives CL. p53: More research and more questions. Cell Death Differ 2006;13:877–80.
- Malumbres M, Barbacid M. RAS oncogenes: The first 30 years. Nat Rev Cancer 2003;3:459–65.
- Lee JW, Soung YH, Kim SY, Lee HW, Park WS, Nam SW, . PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas. Oncogene 2005;24: 1477–80.
- Lee SH, Shin MS, Park WS, Kim SY, Kim HS, Han JY, . Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer. Oncogene 1999;18:3754–60.